ProShare Advisors LLC

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 1357955 BETHESDA, MD

Position in EWTX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$523,720

+$64,513 QoQ

Shares Held

12,890

-11.6% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#135

of 223 holders

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. EWTX ranks #51 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	287,847	$142,982,240
2	REGN	Regeneron Pharmaceuticals, Inc.	119,240	$74,350,909
3	ALNY	Alnylam Pharmaceuticals, Inc.	128,514	$38,686,569
4	INCY	Incyte Corp	48,152	$5,458,510
5	MRNA	Moderna, Inc.	70,621	$4,945,588
6	CYTK	Cytokinetics Inc	27,121	$2,310,437
7	TECH	BIO-TECHNE Corp	30,597	$2,161,678
8	KRYS	Krystal Biotech, Inc.	4,760	$1,769,149

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$523,720	12,890	-11.6%	Shares	Sole	2026-08-11
2026-03-31	$459,207	14,578	-14.1%	Shares	Sole	2026-04-27
2025-12-31	$421,259	16,976	+11.0%	Shares	Sole	2026-02-06
2025-09-30	$248,020	15,291	-19.0%	Shares	Sole	2025-11-06
2025-06-30	$247,621	18,888	-6.5%	Shares	Sole	2025-08-07
2025-03-31	$444,466	20,203	-19.0%	Shares	Sole	2025-05-08
2024-12-31	$665,577	24,928	+29.4%	Shares	Sole	2025-02-14
2024-09-30	$514,022	19,259	+42.8%	Shares	Sole	2024-11-14
2024-06-30	$242,954	13,490	-20.1%	Shares	Sole	2024-08-13
2024-03-31	$307,982	16,885	+51.6%	Shares	Sole	2024-05-08
2023-12-31	$121,838	11,137	+10.2%	Shares	Sole	2024-02-14
2022-12-31	$90,338	10,105	-18.4%	Shares	Sole	2023-02-02
2022-03-31	$120,066	12,378	-19.6%	Shares	Sole	2022-05-10
2021-12-31	$235,205	15,393	—	Shares	Sole	2022-02-08
No filing history on record for this holder in this stock.